Latest Statin Stories
The attorneys at Bernstein Liebhard LLP are investigating claims by potential Lipitor lawsuit claimants who may have developed Type 2 diabetes after taking the cholesterol-lowering statin.
RUTHERFORD-2 Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Jan.
The Firm is investigating Lipitor lawsuits on behalf of individuals who developed Type 2 diabetes, allegedly due to their use of the statin medication. New York,
A new analysis of animal studies on cholesterol-lowering statins by UC San Francisco researchers found that non-industry studies had results that favored the drugs even more than studies funded by industry.
Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Jan.
Up to 30 percent of heart attack patients suffer a new heart attack because cardiologists are unable to control inflammation inside heart arteries — the process that leads to clots rupturing and causing myocardial infarction or stroke.
Icahn School of Medicine at Mount Sinai Designs HDL Nanoparticle to Deliver Statin Medication Inside Inflamed Blood Vessels to Prevent Repeat Heart Attacks and Stroke New
The Firm is investigating Lipitor lawsuits on behalf of patients who developed Type 2 diabetes, allegedly due to Lipitor. New York, NY (PRWEB) January 14, 2014
A study led by researchers at the University of California, San Diego School of Medicine shows that one of the most widely used systems for predicting risk of adverse heart events should be re-evaluated.
Beat Cholesterol In 30 Days designed by Scott Davis is the latest program that teaches people how to manage their hypercholesterolemia quickly and naturally.